Emma Claremont
Member
- Messages
- 6
- Location
- UK
Hello,
I've been a long-term "lurker"! I've read most posts during the last 12 months, but this is my first time, and I thought it might be something of interest to those amongst us whose health is dependent upon insulin injections.
I've recently discovered that 3 different studies carried out in Sweden, Germany and Scotland have revealed that there might (just "might") be a link between Lantus and cancer, particularly in Type 2s who use Lantus as mono-therapy (i.e. they don't use a rapid acting insulin as well as their basal insulin).
The European Association for the Study of Diabetes published a press release (26/06/2009) titled "Lantus insulin: a possible link with cancer which requires further investigation", this has been passed to the European Medicines Agency (EMEA), who have said the report is not conclusive, and that a relationship between insulin glargine (Lantus) and cancer cannot be confirmed nor excluded, but have suggested that the EASD report requires further in-depth evaluation.
For a little more information take a look at http://www.wightneedles.co.uk/insulin/lantus-glargine-insulin/
Sorry to not to write some positive news in my first posting, but I thought the information might be important.
Emma
I've been a long-term "lurker"! I've read most posts during the last 12 months, but this is my first time, and I thought it might be something of interest to those amongst us whose health is dependent upon insulin injections.
I've recently discovered that 3 different studies carried out in Sweden, Germany and Scotland have revealed that there might (just "might") be a link between Lantus and cancer, particularly in Type 2s who use Lantus as mono-therapy (i.e. they don't use a rapid acting insulin as well as their basal insulin).
The European Association for the Study of Diabetes published a press release (26/06/2009) titled "Lantus insulin: a possible link with cancer which requires further investigation", this has been passed to the European Medicines Agency (EMEA), who have said the report is not conclusive, and that a relationship between insulin glargine (Lantus) and cancer cannot be confirmed nor excluded, but have suggested that the EASD report requires further in-depth evaluation.
For a little more information take a look at http://www.wightneedles.co.uk/insulin/lantus-glargine-insulin/
Sorry to not to write some positive news in my first posting, but I thought the information might be important.
Emma